Potential and opportunities for use of recombinant lactic acid bacteria in human health.
about
Lysate of probiotic Lactobacillus casei DN-114 001 ameliorates colitis by strengthening the gut barrier function and changing the gut microenvironmentHeterologous production of human papillomavirus type-16 L1 protein by a lactic acid bacteriumLactobacilli activate human dendritic cells that skew T cells toward T helper 1 polarizationBiography of Todd R. Klaenhammer.Intranasal coadministration of live lactococci producing interleukin-12 and a major cow's milk allergen inhibits allergic reaction in mice.Modelling strategies for the industrial exploitation of lactic acid bacteria.Actual concept of "probiotics": is it more functional to science or business?Targeting mucosal dendritic cells with microbial antigens from probiotic lactic acid bacteria.Genome analysis of food grade lactic Acid-producing bacteria: from basics to applications.Lactobacillus plantarum DK119 as a probiotic confers protection against influenza virus by modulating innate immunityUpdate on Campylobacter jejuni vaccine development for preventing human campylobacteriosis.Oral immunization with recombinant Lactobacillus acidophilus expressing the adhesin Hp0410 of Helicobacter pylori induces mucosal and systemic immune responses.The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases.In vitro degradation of oxalate by recombinant Lactobacillus plantarum expressing heterologous oxalate decarboxylase.Repetitive, marker-free, site-specific integration as a novel tool for multiple chromosomal integration of DNA.Biocontainment strategies for live lactic acid bacteria vaccine vectors.Integrative expression system for delivery of antibody fragments by lactobacilli.A new plasmid vector for DNA delivery using lactococci.In vitro assessment of functional properties of lactic acid bacteria isolated from faecal microbiota of healthy dogs for potential use as probiotics.Heat-killed Lactobacillus casei confers broad protection against influenza A virus primary infection and develops heterosubtypic immunity against future secondary infection.Simultaneous lactic acidification and coagulation by using recombinant Lactococcus lactis strain.Metabolic engineering of Lactococcus lactis influence of the overproduction of lipase enzyme.Mobile group II intron based gene targeting in Lactobacillus plantarum WCFS1.
P2860
Q21562212-7E5F7F7D-5147-43BD-92C5-2EC82729BF12Q33496351-CE979DE4-808C-49FA-9067-5C6FA57CE02FQ33864114-A0693475-59E1-45F1-8B5D-264FFC67D3FAQ33932580-631A0C18-DE9D-4C1D-998E-67F222753C1BQ35690028-FBBA8099-6ABD-4A91-959C-C9648DAD8735Q36343560-9C996979-8032-4CA5-B454-E5CD340EE716Q36699182-9CE1AD33-79E1-441A-88EB-E4F8DA106281Q37103921-1DF45400-DC43-43DB-B23F-BBF9D28604DFQ37185713-8A4213D3-9C02-4508-AEA6-A346B96EE51EQ37215818-E8FE716A-2E3A-4852-953C-CE9F6CD2F79AQ37461382-1FBC3D8C-F3EB-4B05-BCB0-B26306D0A462Q37545006-1E5E4B71-C148-4F25-9313-6F0D4277C8B6Q37729525-C4072492-F82D-4A28-9A45-6CC05A01D726Q39407773-794416AA-13D1-4A7B-B263-68228928F158Q41844630-E294FDB8-E456-417D-A68D-CFD99B5B8E55Q42161475-2BCD7D27-7945-493A-9474-5AA2845894C6Q42706463-77AACFA2-495D-469F-A3D4-38A2D528CBF4Q43176145-FC349883-545D-46BB-956B-BA2D63B95FE7Q46577670-CA6F4B30-17AE-4B13-B0F5-A589A0C49DE3Q47132462-7B9D1555-C2D7-4000-87E6-A371ED4165F7Q47845498-BBCB4180-7CB6-4BC2-A63C-4D49B3D8B1ACQ50229264-A543C21B-2088-466B-A046-FE909EEB8623Q50658168-6ED5FCDE-DAC5-40F6-BB6E-341147340830
P2860
Potential and opportunities for use of recombinant lactic acid bacteria in human health.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Potential and opportunities for use of recombinant lactic acid bacteria in human health.
@ast
Potential and opportunities for use of recombinant lactic acid bacteria in human health.
@en
type
label
Potential and opportunities for use of recombinant lactic acid bacteria in human health.
@ast
Potential and opportunities for use of recombinant lactic acid bacteria in human health.
@en
prefLabel
Potential and opportunities for use of recombinant lactic acid bacteria in human health.
@ast
Potential and opportunities for use of recombinant lactic acid bacteria in human health.
@en
P2093
P1476
Potential and opportunities for use of recombinant lactic acid bacteria in human health.
@en
P2093
Andreas Repa
Annick Mercenier
Astrid Vrang
Catherine Daniel
Hana Kozakova
Hans Israelsen
Helena Tlaskolova
Jean Delcour
Jean Fioramonti
Jerry Wells
P356
10.1016/S0065-2164(04)56001-X
P577
2004-01-01T00:00:00Z